The sensitive skin segment is one of the fastest-growing in the global cosmetic market, with an estimated 50–70% of women and 40–60% of men reporting at least occasionally sensitive skin. For cosmetic brands targeting this segment, testing is not optional — it is the cornerstone of product positioning and consumer trust.
Yet testing on sensitive or reactive skin panels requires specific adaptations to standard hydration protocols. This article explains what makes these studies different, what endpoints to include, and how to communicate results credibly.
1. Defining ‘Sensitive Skin’: A Heterogeneous Concept
‘Sensitive skin’ is not a single clinical condition. It encompasses a broad spectrum of presentations, from cosmetically dry and reactive skin to clinically diagnosed conditions such as rosacea, atopic dermatitis, and contact dermatitis.
For testing purposes, it is essential to define the target population precisely:
- Self-declared sensitive skin: recruitment based on questionnaire (Sensitive Scale, ECCA grading)
- Clinically validated sensitive skin: subjects with documented atopic or rosacea history
- Barrier-compromised skin: subjects with elevated baseline TEWL (>15–20 g/m²/h)
The more specific the panel definition, the more precise — and defensible — the claim.
2. Why Standard Protocols Need Adaptation
| Standard protocol parameter | Challenge for sensitive skin | Adaptation required |
| Wash-out period (12–24h) | May cause discomfort for very dry/reactive skin | Reduce or allow gentle cleanser only |
| Provocation tests (SLS patch) | Risk of excessive reaction | Use lower concentration or omit |
| Application site (forearm) | May not reflect facial reactivity | Add face site with appropriate probes |
| Panel size (20–30 subjects) | Harder to recruit validated sensitive subjects | Allow longer recruitment window; 25–40 recommended |
| Single product application | Skin condition may vary significantly between visits | Add baseline stabilization visit |
| Ambient conditions (20°C, 50% RH) | Same — no adaptation needed | — |
3. Key Endpoints in Sensitive Skin Hydration Studies
Instrumental endpoints
- Corneometry (SC hydration): primary efficacy endpoint
- TEWL (Tewameter, Aquaflux): barrier function, central for compromised-skin claims
- Skin surface pH: relevant for microbiome-friendly and barrier claims
- Erythema index (Mexameter, Colorimetry): tolerance marker — critical for reactive skin
- Skin roughness (Visioscan, Primos): texture and comfort assessment
Clinical and self-assessment endpoints
- Dermatologist skin tolerance assessment: mandatory for ‘dermatologically tested’ and ‘suitable for sensitive skin’ claims
- Self-assessment questionnaire: comfort, tightness, tingling, itching — validated scales (NRS, VAS)
- Consumer perception: overall satisfaction, perceived tolerance, repurchase intent
Note: combining instrumental and subjective data significantly strengthens the claim dossier and allows multi-angle communication.
4. Protocol Design: A Recommended Framework
| Parameter | Recommendation for sensitive skin |
| Panel size | 25–40 subjects; self-declared or clinically validated sensitive skin |
| Recruitment criteria | Sensitive Scale score ≥ 3; or elevated TEWL; or diagnosed condition |
| Wash-out | 12h; gentle fragrance-free cleanser authorized |
| Application protocol | Twice daily for 28 days (single application insufficient for barrier claims) |
| Measurement sites | Forearm (standardized) + face (optional, adapted probe) |
| Instrumental endpoints | Corneometry + TEWL + Mexameter (erythema) |
| Clinical assessment | Dermatologist evaluation at T0, T+14 days, T+28 days |
| Subjective assessment | Validated questionnaire at T0, T+14 days, T+28 days |
| Primary time points | T0, T+1h, T+14 days, T+28 days |
| Safety monitoring | Adverse event recording throughout the study |
5. Claim Communication: What’s Allowed and What Isn’t
‘Dermatologically tested’: this claim requires a dermatologist-supervised study with formal tolerance assessment. It says nothing about efficacy — it only means the product was tested on volunteers under dermatological supervision.
‘Suitable for sensitive skin’: stronger claim, requires both tolerance data (no adverse reactions in the sensitive panel) and efficacy data (hydration improvement in the same panel).
‘Tested under dermatological control’: equivalent to ‘dermatologically tested’ — requires the same evidence.
‘Hypoallergenic’: legally undefined in many markets. Requires robust patch test data and ideally a negative Repeated Insult Patch Test (RIPT) study.
Conclusion
Testing hydration in sensitive and reactive skin populations is more demanding than in standard panels — but it unlocks the ability to make more specific and compelling claims. The key is to align panel selection, study design, and endpoint selection with the precise claim you want to support.
Skinobs references CROs with dedicated sensitive skin panels across Europe, Asia, and North America. Use www.skinobs.com to filter by specialty, accreditation, and panel type.
